<?xml version='1.0' encoding='utf-8'?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>The Honor Daily</title>
    <link>https://bookwithhonor.com/news/</link>
    <description>Connor MacIvor's dated, sourced newspaper on world affairs, property, AI, health evidence and ideas worth finishing.</description>
    <language>en-us</language>
    <item>
      <title>The Honor Daily · No. 003 · Hormuz talks meet a public rejection; SCV markets diverge</title>
      <link>https://bookwithhonor.com/news/2026-09-27-am/</link>
      <guid>https://bookwithhonor.com/news/2026-09-27-am/</guid>
      <description>Issue 003 is live. Sunday brings a public U.S. rejection of Iran’s conditional Hormuz proposal, a fresh Santa Clarita housing-type ledger, and dated evidence on AI agent incidents and health claims. No ceasefire or reopening is verified.

Inside this issue:
• Trump publicly rejected Iran’s Hormuz proposal; Iran says mediators have not conveyed a final U.S. answer, and no reopening is verified.
• At the 06:40 PDT SCV snapshot, 840 residential listings were active and 214 closed in the source 30-day window; single-family supply was 3.0 months versus 8.8 for condos.
• Reuters reported Friday that OpenAI disclosed 53 user images leaked by research agents; the full scope remains under investigation.
• FDA cites a randomized testosterone safety trial with 7.0% versus 7.3% major cardiovascular events in enrolled men; that does not establish a universal anti-aging benefit.</description>
      <pubDate>Sun, 27 Sep 2026 13:46:23 +0000</pubDate>
      <content:encoded>&lt;p&gt;Issue 003 is live. Sunday brings a public U.S. rejection of Iran’s conditional Hormuz proposal, a fresh Santa Clarita housing-type ledger, and dated evidence on AI agent incidents and health claims. No ceasefire or reopening is verified.&lt;/p&gt;&lt;ul&gt;&lt;li&gt;Trump publicly rejected Iran’s Hormuz proposal; Iran says mediators have not conveyed a final U.S. answer, and no reopening is verified.&lt;/li&gt;&lt;li&gt;At the 06:40 PDT SCV snapshot, 840 residential listings were active and 214 closed in the source 30-day window; single-family supply was 3.0 months versus 8.8 for condos.&lt;/li&gt;&lt;li&gt;Reuters reported Friday that OpenAI disclosed 53 user images leaked by research agents; the full scope remains under investigation.&lt;/li&gt;&lt;li&gt;FDA cites a randomized testosterone safety trial with 7.0% versus 7.3% major cardiovascular events in enrolled men; that does not establish a universal anti-aging benefit.&lt;/li&gt;&lt;/ul&gt;</content:encoded>
    </item>
    <item>
      <title>The Honor Daily · No. 002 · Trade promises meet the implementation test</title>
      <link>https://bookwithhonor.com/news/2026-09-26-pm/</link>
      <guid>https://bookwithhonor.com/news/2026-09-26-pm/</guid>
      <description>Issue 002 is live. The September 26 launch issue was published earlier, but no separate morning edition or morning email was sent today. This afternoon adds the post-summit documents, a fresh SCV market snapshot, and the evidence status across AI and health.

Inside this issue:
• The White House describes recommendations for tariff treatment on $30 billion in goods each way, not verified tariff cuts in force.
• At the 16:00 PDT SCV snapshot: 841 active listings and 221 closings in the source 30-day window; single-family and condo supply point in different directions.
• U.S. officials announced an AI incident channel with China; procedures and performance remain unverified.
• Freddie Mac’s latest weekly 30-year average remains 7.03%, dated September 24; no new afternoon rate release.</description>
      <pubDate>Sat, 26 Sep 2026 23:12:33 +0000</pubDate>
      <content:encoded>&lt;p&gt;Issue 002 is live. The September 26 launch issue was published earlier, but no separate morning edition or morning email was sent today. This afternoon adds the post-summit documents, a fresh SCV market snapshot, and the evidence status across AI and health.&lt;/p&gt;&lt;ul&gt;&lt;li&gt;The White House describes recommendations for tariff treatment on $30 billion in goods each way, not verified tariff cuts in force.&lt;/li&gt;&lt;li&gt;At the 16:00 PDT SCV snapshot: 841 active listings and 221 closings in the source 30-day window; single-family and condo supply point in different directions.&lt;/li&gt;&lt;li&gt;U.S. officials announced an AI incident channel with China; procedures and performance remain unverified.&lt;/li&gt;&lt;li&gt;Freddie Mac’s latest weekly 30-year average remains 7.03%, dated September 24; no new afternoon rate release.&lt;/li&gt;&lt;/ul&gt;</content:encoded>
    </item>
    <item>
      <title>The Honor Daily · No. 001 · Launch edition</title>
      <link>https://bookwithhonor.com/news/2026-09-26/</link>
      <guid>https://bookwithhonor.com/news/2026-09-26/</guid>
      <description>Inside No. 001: four concrete threads from the dated launch edition. Read the full paper for sources, caveats, and Connor’s analysis.

Inside this issue:
• World: A two-month U.S.–China trade-truce extension buys time; tariffs and technology limits remain unsettled.
• Santa Clarita housing: the launch snapshot shows about 3.0 months of single-family supply versus 8.8 for condos.
• AI: Safety disclosures are useful, but the conditions of the tests matter before calling a system safe or unsafe.
• Health: The FDA changed testosterone-therapy labeling; the blood-pressure warning still deserves attention.</description>
      <pubDate>Sat, 26 Sep 2026 21:06:51 +0000</pubDate>
      <content:encoded>&lt;p&gt;Inside No. 001: four concrete threads from the dated launch edition. Read the full paper for sources, caveats, and Connor’s analysis.&lt;/p&gt;&lt;ul&gt;&lt;li&gt;World: A two-month U.S.–China trade-truce extension buys time; tariffs and technology limits remain unsettled.&lt;/li&gt;&lt;li&gt;Santa Clarita housing: the launch snapshot shows about 3.0 months of single-family supply versus 8.8 for condos.&lt;/li&gt;&lt;li&gt;AI: Safety disclosures are useful, but the conditions of the tests matter before calling a system safe or unsafe.&lt;/li&gt;&lt;li&gt;Health: The FDA changed testosterone-therapy labeling; the blood-pressure warning still deserves attention.&lt;/li&gt;&lt;/ul&gt;</content:encoded>
    </item>
  </channel>
</rss>